These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8743280)

  • 1. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
    Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A
    J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary output of hydroxylysine glycosides and pyridinium cross-links in detecting rat bone collagen turnover rate.
    Grazioli V; Alfano M; Stenico A; Casari E
    FEBS Lett; 1996 Jun; 388(2-3):134-8. PubMed ID: 8690072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women.
    Sirtori P; Sosio C; Polo RM; Tenni R; Rubinacci A
    Pharmacol Res; 1997 Sep; 36(3):229-35. PubMed ID: 9367668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17 beta-estradiol replacement in aged rats.
    Pecile A; Netti C; Sibilia V; Villa I; Calori G; Tenni R; Coluzzi M; Moro GL; Rubinacci A
    J Endocrinol; 1996 Sep; 150(3):383-90. PubMed ID: 8882157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodelling in postmenopausal women.
    Sirtori P; Sosio C; Resmini G; Rubinacci A
    Pharmacol Res; 1996 Jun; 33(6):353-9. PubMed ID: 8971958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
    Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
    Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A; Hassager C; Delmas PD; Christiansen C
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis.
    Bettica P; Taylor AK; Talbot J; Moro L; Talamini R; Baylink DJ
    J Clin Endocrinol Metab; 1996 Feb; 81(2):542-6. PubMed ID: 8636265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown.
    Grazioli V; Casari E; Murone M; Bonini PA
    J Chromatogr; 1993 May; 615(1):59-66. PubMed ID: 8340463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D; Schlemmer A; Johansen JS; Gineyts E; Christiansen C; Delmas PD
    J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.
    Chen JT; Hosoda K; Hasumi K; Ogata E; Shiraki M
    J Bone Miner Res; 1996 Nov; 11(11):1784-92. PubMed ID: 8915787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover during hormone replacement therapy.
    Masahashi T; Negoro Y; Kuroki T; Asai M; Noguchi M; Nakanishi M
    Int J Gynaecol Obstet; 1999 Feb; 64(2):163-6. PubMed ID: 10189026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary galactosyl-hydroxylysine in postmenopausal osteoporotic women: A potential marker of bone fragility.
    Lo Cascio V; Bertoldo F; Gambaro G; Gasperi E; Furlan F; Colapietro F; Lo Cascio C; Campagnola M
    J Bone Miner Res; 1999 Aug; 14(8):1420-4. PubMed ID: 10457275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovariectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues.
    Casari E; Alfano M; Valente M; Clarke GD; Ferni G; Grazioli B
    Osteoporos Int; 1997; 7(6):539-43. PubMed ID: 9604049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary deoxypyridinoline is a useful biochemical bone marker for the management of postmenopausal osteoporosis.
    Yu SL; Ho LM; Lim BC; Sim ML
    Ann Acad Med Singap; 1998 Jul; 27(4):527-9. PubMed ID: 9791660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis.
    Fledelius C; Riis BJ; Overgaard K; Christiansen C
    Calcif Tissue Int; 1994 May; 54(5):381-4. PubMed ID: 8062154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.